Newsroom and media
Founder commentary
NICE approval is not enough: why the UK's next medicines challenge is operational delivery
Manufacturing Chemist commentary on the operational work required after a positive NICE recommendation. Recommendation is one milestone; it is not marketing authorisation or evidence that NEUVIOR has delivered a service or outcome.
Coverage held by the publisher
NEUVIOR does not reproduce publisher copy, PDFs or article imagery. Use the source publication link above to read the publisher’s record.
After publication
After NICE: making medicines access operational
A recommendation can clarify what should be available. You still need an accountable route from evidence to a local decision, delivery and review.
This is a later NEUVIOR founder reflection, not publisher copy or evidence of endorsement, adoption, deployment or outcomes.